{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T23:57:50Z","timestamp":1785196670705,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T00:00:00Z","timestamp":1709337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T00:00:00Z","timestamp":1709337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V111C-162"],"award-info":[{"award-number":["V111C-162"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>\n                        Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Although peripheral vestibular disorder is a non-fatal complication of Fabry disease, fatalities have been reported in some case reports and case series. To date, no studies have examined the relative risk of peripheral vestibular disorder in patients with Fabry disease compared to the general population without the condition. Due to the high prevalence of Fabry disease in East Asia and the potential shared pathogenic pathways between Fabry disease and vasculopathy, we conducted a study using a nationwide population-based dataset to compare the prevalence of peripheral vestibular disorder between patients with Fabry disease and matched comparison patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Data was sourced from Taiwan\u2019s Longitudinal Health Insurance Database 2010. this study consists of 11,668 sampled patients, 2917 study patients with Fabry disease and 8751 propensity-score-matching comparison patients. We conducted multiple logistic regression analysis to study the association between peripheral vestibular disorder and Fabry disease.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The study identified notable differences in the prevalence of various vestibular disorders between the study and comparison groups. Specifically, there was a 7.2% increased prevalence of peripheral vestibular disorder in the study group (28.3%) compared to the comparison group (20.9%), Meniere\u2019s disease (5.4% vs. 3.7%), benign paroxysmal positional vertigo (5.1% vs. 3.3%), and other\/ unspecified peripheral vestibular dizziness (15.6% vs. 11.8%) (all <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). The odds ratios for PVD, MD, BPPV, and other PVD were 1.44 (95% CI\u2009=\u20091.29\u20131.60), 1.50 (95% CI\u2009=\u20091.23\u20131.83), 1.59 (95% CI\u2009=\u20091.30\u20131.95), and 1.40 (95% CI\u2009=\u20091.24\u20131.58), respectively, among the Fabry disease group relative to the comparison group after adjusting for age, monthly income, geographic location, urbanization level, hyperlipidemia, diabetes, coronary heart disease, and hypertension.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study found that patients with Fabry disease had increased prevalence of peripheral vestibular disorder.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-024-03088-y","type":"journal-article","created":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T18:01:24Z","timestamp":1709402484000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Increased prevalence of peripheral vestibular disorder among patients with Fabry disease"],"prefix":"10.1186","volume":"19","author":[{"given":"Tzong-Hann","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudha","family":"Xirasagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Fu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Shyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4661-959X","authenticated-orcid":false,"given":"Herng-Ching","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,2]]},"reference":[{"issue":"Suppl 1","key":"3088_CR1","doi-asserted-by":"publisher","first-page":"s10","DOI":"10.1590\/1806-9282.66.s1.10","volume":"66Suppl 1","author":"TP Bernardes","year":"2020","unstructured":"Bernardes TP, Foresto RD, Kirsztajn GM. Fabry disease: genetics, pathology, and treatment. Rev Assoc Med Bras (1992). 2020;66Suppl 1(Suppl 1):s10\u20136.","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"3088_CR2","doi-asserted-by":"crossref","unstructured":"Cheng YF et al. Association of Fabry Disease with hearing loss, Tinnitus, and Sudden hearing loss: a Nationwide Population-based study. J Clin Med, 2022. 11(24).","DOI":"10.3390\/jcm11247396"},{"key":"3088_CR3","unstructured":"Strupp M, Dieterich M, Brandt T. The treatment and natural course of peripheral and central vertigo. Dtsch Arztebl Int, 2013. 110(29\u201330): p. 505\u2013\u200915; quiz 515-6."},{"issue":"3","key":"3088_CR4","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/lary.28877","volume":"131","author":"TH Yang","year":"2021","unstructured":"Yang TH, et al. Peripheral vestibular disorders: nationwide evidence from Taiwan. Laryngoscope. 2021;131(3):639\u201343.","journal-title":"Laryngoscope"},{"issue":"7","key":"3088_CR5","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1002\/lary.29519","volume":"131","author":"TH Yang","year":"2021","unstructured":"Yang TH, et al. Increased risk of Injury following a diagnosis of Vertigo: a Population-based study. Laryngoscope. 2021;131(7):1633\u20138.","journal-title":"Laryngoscope"},{"key":"3088_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/B978-0-444-63437-5.00005-4","volume":"137","author":"HK Neuhauser","year":"2016","unstructured":"Neuhauser HK. The epidemiology of dizziness and vertigo. Handb Clin Neurol. 2016;137:67\u201382.","journal-title":"Handb Clin Neurol"},{"issue":"5","key":"3088_CR7","doi-asserted-by":"publisher","first-page":"478","DOI":"10.3988\/jcn.2022.0463","volume":"19","author":"HJ Kim","year":"2023","unstructured":"Kim HJ, Lee JO, Kim JS. Otoconial Degeneration after transient Ischemia Induced by four-vessel occlusion in rats. J Clin Neurol. 2023;19(5):478\u201382.","journal-title":"J Clin Neurol"},{"key":"3088_CR8","doi-asserted-by":"publisher","first-page":"818533","DOI":"10.3389\/fneur.2022.818533","volume":"13","author":"FK Oussoren","year":"2022","unstructured":"Oussoren FK, et al. Cerebral small Vessel Disease in Elderly patients with vestibular neuritis. Front Neurol. 2022;13:818533.","journal-title":"Front Neurol"},{"issue":"3","key":"3088_CR9","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1177\/0194599818773077","volume":"159","author":"JS Phillips","year":"2018","unstructured":"Phillips JS, et al. Clinical subtyping of M\u00e9ni\u00e8re\u2019s Disease. Otolaryngol Head Neck Surg. 2018;159(3):407\u20139.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"11","key":"3088_CR10","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1097\/GIM.0b013e3181bb05bb","volume":"11","author":"S Waldek","year":"2009","unstructured":"Waldek S, et al. Life expectancy and cause of death in males and females with fabry disease: findings from the Fabry Registry. Genet Med. 2009;11(11):790\u20136.","journal-title":"Genet Med"},{"issue":"1","key":"3088_CR11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13023-018-0882-7","volume":"13","author":"M K\u00f6ping","year":"2018","unstructured":"K\u00f6ping M, et al. Characterization of vertigo and hearing loss in patients with fabry disease. Orphanet J Rare Dis. 2018;13(1):137.","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"3088_CR12","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.anorl.2019.04.014","volume":"136","author":"C Eyermann","year":"2019","unstructured":"Eyermann C, et al. Cochleovestibular manifestations in fabry disease: importance of screening and systematic ENT evaluation. Eur Ann Otorhinolaryngol Head Neck Dis. 2019;136(4):273\u20139.","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"issue":"6","key":"3088_CR13","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.ejmg.2018.01.006","volume":"61","author":"J Rodrigues","year":"2018","unstructured":"Rodrigues J, et al. Inner ear involvement in fabry disease: clinical and audiometric evaluation of a large cohort of patients followed in a reference centre. Eur J Med Genet. 2018;61(6):341\u20137.","journal-title":"Eur J Med Genet"},{"issue":"3","key":"3088_CR14","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1007\/s00405-021-07173-x","volume":"279","author":"A Asquier-Khati","year":"2022","unstructured":"Asquier-Khati A, et al. Cochleovestibular involvement in patients with fabry disease: data from the multicenter cohort FFABRY. Eur Arch Otorhinolaryngol. 2022;279(3):1639\u201344.","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"1","key":"3088_CR15","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s13023-022-02392-9","volume":"17","author":"M Beck","year":"2022","unstructured":"Beck M, et al. Twenty years of the Fabry Outcome Survey (FOS): insights, achievements, and lessons learned from a global patient registry. Orphanet J Rare Dis. 2022;17(1):238.","journal-title":"Orphanet J Rare Dis"},{"issue":"10","key":"3088_CR16","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1007\/s00415-007-0575-y","volume":"254","author":"A Palla","year":"2007","unstructured":"Palla A, et al. Vestibular and auditory deficits in fabry disease and their response to enzyme replacement therapy. J Neurol. 2007;254(10):1433\u201342.","journal-title":"J Neurol"},{"issue":"443","key":"3088_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1651-2227.2003.tb00220.x","volume":"92","author":"A Palla","year":"2003","unstructured":"Palla A, Widmer U, Straumann D. Head-impulse testing in fabry disease\u2013vestibular function in male and female patients. Acta Paediatr Suppl. 2003;92(443):38\u201342. discussion 27.","journal-title":"Acta Paediatr Suppl"},{"issue":"443","key":"3088_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1651-2227.2003.tb00219.x","volume":"92","author":"G Conti","year":"2003","unstructured":"Conti G, Sergi B. Auditory and vestibular findings in fabry disease: a study of hemizygous males and heterozygous females. Acta Paediatr Suppl. 2003;92(443):33\u20137. discussion 27.","journal-title":"Acta Paediatr Suppl"},{"issue":"2","key":"3088_CR19","doi-asserted-by":"publisher","first-page":"176","DOI":"10.4081\/audiores.2017.176","volume":"7","author":"S Carmona","year":"2017","unstructured":"Carmona S, et al. Neuro-otological and peripheral nerve involvement in Fabry Disease. Audiol Res. 2017;7(2):176.","journal-title":"Audiol Res"},{"key":"3088_CR20","doi-asserted-by":"publisher","first-page":"856946","DOI":"10.3389\/fneur.2022.856946","volume":"13","author":"L Peultier-Celli","year":"2022","unstructured":"Peultier-Celli L, et al. Balance control impairments in fabry disease. Front Neurol. 2022;13:856946.","journal-title":"Front Neurol"},{"issue":"5 Pt 1","key":"3088_CR21","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1177\/000348948909800509","volume":"98","author":"PA Schachern","year":"1989","unstructured":"Schachern PA, et al. Otologic histopathology of Fabry\u2019s disease. Ann Otol Rhinol Laryngol. 1989;98(5 Pt 1):359\u201363.","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"3088_CR22","unstructured":"Staughton RB. Angiokeratoma corporis diffusum (fabry). Arch Dermatol 1959. 79 p. 601\u20132."},{"issue":"1","key":"3088_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/VES-150549","volume":"25","author":"JA Lopez-Escamez","year":"2015","unstructured":"Lopez-Escamez JA, et al. Diagnostic criteria for Meni\u00e8re\u2019s disease. J Vestib Res. 2015;25(1):1\u20137.","journal-title":"J Vestib Res"},{"issue":"6","key":"3088_CR24","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/j.mehy.2013.10.015","volume":"81","author":"CA Foster","year":"2013","unstructured":"Foster CA, Breeze RE. The Meniere attack: an ischemia\/reperfusion disorder of inner ear sensory tissues. Med Hypotheses. 2013;81(6):1108\u201315.","journal-title":"Med Hypotheses"},{"issue":"3","key":"3088_CR25","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.otc.2011.03.004","volume":"44","author":"MJ Derebery","year":"2011","unstructured":"Derebery MJ. Allergic and immunologic features of M\u00e9ni\u00e8re\u2019s disease. Otolaryngol Clin North Am. 2011;44(3):655\u201366. ix.","journal-title":"Otolaryngol Clin North Am"},{"issue":"11","key":"3088_CR26","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1212\/01.WNL.0000036903.22461.39","volume":"59","author":"A Radtke","year":"2002","unstructured":"Radtke A, et al. Migraine and M\u00e9ni\u00e8re\u2019s disease: is there a link? Neurology. 2002;59(11):1700\u20134.","journal-title":"Neurology"},{"issue":"4","key":"3088_CR27","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1001\/archotol.1995.01890040005001","volume":"121","author":"W Parker","year":"1995","unstructured":"Parker W. Meni\u00e8re\u2019s disease. Etiologic considerations. Arch Otolaryngol Head Neck Surg. 1995;121(4):377\u201382.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"2","key":"3088_CR28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.joto.2019.01.004","volume":"14","author":"\u00c2 Rego","year":"2019","unstructured":"Rego \u00c2. The cardiovascular aspects of a M\u00e9ni\u00e8re\u2019s disease population - A pilot study. J Otol. 2019;14(2):51\u20136.","journal-title":"J Otol"},{"issue":"2","key":"3088_CR29","first-page":"87","volume":"30","author":"B Sergi","year":"2010","unstructured":"Sergi B, Conti G, Paludetti G. Inner ear involvement in Anderson-Fabry disease: long-term follow-up during enzyme replacement therapy. Acta Otorhinolaryngol Ital. 2010;30(2):87\u201393.","journal-title":"Acta Otorhinolaryngol Ital"},{"issue":"3","key":"3088_CR30","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/lary.26115","volume":"127","author":"WT Kao","year":"2017","unstructured":"Kao WT, Parnes LS, Chole RA. Otoconia and otolithic membrane fragments within the posterior semicircular canal in benign paroxysmal positional vertigo. Laryngoscope. 2017;127(3):709\u201314.","journal-title":"Laryngoscope"},{"issue":"3","key":"3088_CR31","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.otohns.2010.06.905","volume":"143","author":"NH Lee","year":"2010","unstructured":"Lee NH, et al. Benign paroxysmal positional vertigo secondary to inner ear disease. Otolaryngol Head Neck Surg. 2010;143(3):413\u20137.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"5","key":"3088_CR32","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1007\/s00415-019-09502-x","volume":"268","author":"MA Kutlubaev","year":"2021","unstructured":"Kutlubaev MA, Xu Y, Hornibrook J. Benign paroxysmal positional vertigo in Meniere\u2019s disease: systematic review and meta-analysis of frequency and clinical characteristics. J Neurol. 2021;268(5):1608\u201314.","journal-title":"J Neurol"},{"key":"3088_CR33","doi-asserted-by":"crossref","unstructured":"Sfakianaki I et al. Risk factors for recurrence of Benign Paroxysmal positional Vertigo. A clinical review. J Clin Med, 2021. 10(19).","DOI":"10.3390\/jcm10194372"},{"issue":"8","key":"3088_CR34","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1097\/00005537-200408000-00020","volume":"114","author":"JC Amor-Dorado","year":"2004","unstructured":"Amor-Dorado JC, et al. Giant cell arteritis: a new association with benign paroxysmal positional vertigo. Laryngoscope. 2004;114(8):1420\u20135.","journal-title":"Laryngoscope"},{"issue":"7","key":"3088_CR35","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1136\/jnnp.2006.100420","volume":"78","author":"M von Brevern","year":"2007","unstructured":"von Brevern M, et al. Epidemiology of benign paroxysmal positional vertigo: a population based study. J Neurol Neurosurg Psychiatry. 2007;78(7):710\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"3088_CR36","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3233\/VES-220201","volume":"32","author":"M Strupp","year":"2022","unstructured":"Strupp M, et al. Acute unilateral vestibulopathy\/vestibular neuritis: diagnostic criteria. J Vestib Res. 2022;32(5):389\u2013406.","journal-title":"J Vestib Res"},{"key":"3088_CR37","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3389\/fneur.2018.00591","volume":"9","author":"D Rujescu","year":"2018","unstructured":"Rujescu D, et al. Genome-wide Association study in vestibular neuritis: involvement of the host factor for HSV-1 replication. Front Neurol. 2018;9:591.","journal-title":"Front Neurol"},{"key":"3088_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/00016488809098974","volume":"453","author":"P Silvoniemi","year":"1988","unstructured":"Silvoniemi P. Vestibular neuronitis. An otoneurological evaluation. Acta Otolaryngol Suppl. 1988;453:1\u201372.","journal-title":"Acta Otolaryngol Suppl"},{"issue":"8","key":"3088_CR39","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1002\/lary.27084","volume":"128","author":"H Byun","year":"2018","unstructured":"Byun H, et al. Clinical value of 4-hour delayed gadolinium-enhanced 3D FLAIR MR images in Acute vestibular neuritis. Laryngoscope. 2018;128(8):1946\u201351.","journal-title":"Laryngoscope"},{"issue":"8","key":"3088_CR40","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1177\/0003489417718846","volume":"126","author":"Y Oron","year":"2017","unstructured":"Oron Y, et al. Cardiovascular Risk factors among patients with vestibular neuritis. Ann Otol Rhinol Laryngol. 2017;126(8):597\u2013601.","journal-title":"Ann Otol Rhinol Laryngol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03088-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-024-03088-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03088-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T18:02:19Z","timestamp":1709402539000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-024-03088-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,2]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3088"],"URL":"https:\/\/doi.org\/10.1186\/s13023-024-03088-y","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,2]]},"assertion":[{"value":"30 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the institutional review board of Taipei Medical University (TMU-JIRB N202203211) and is compliant with the Declaration of Helsinki. Because we used deidentified administrative data, informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"97"}}